Current Role of Radiotherapy in Non-melanoma Skin Cancer

M.J. Veness, D. Delishaj, E.A. Barnes, A. Bezugly, A. Rembielak

Research output: Contribution to journalArticlepeer-review


Non-melanoma skin cancer (NMSC) represents the most frequently diagnosed malignancy worldwide, most being cutaneous basal cell and squamous cell carcinoma. The global incidence of NMSC continues to increase as the global population ages. Numerous treatment options are available for NMSC patients, with radiotherapy an efficacious and tissue-preserving non-surgical option. External beam radiotherapy and brachytherapy are modalities with specific indications and advantages in treating NMSC. Where excision is not an option (medically/technically inoperable) or considered less ideal (e.g. cosmetic or functional outcome), radiotherapy offers an excellent alternative. Inoperable elderly and/or co-morbid patients of poor performance status can benefit from short-course hypofractionated radiotherapy, with very acceptable toxicity. Adjuvant radiotherapy in patients with unfavourable pathology can decrease the risk of local and regional recurrence and associated morbidity and mortality. Radiotherapy has advantages and disadvantages and it is important for clinicians to understand these. Managing patients with NMSC is carried out by clinicians from multiple disciplines but it is imperative that they are all aware of the role of radiotherapy in their patients in various clinical settings. Here we aim to discuss the role and indications for recommending radiotherapy in patients with NMSC.
Original languageEnglish
Pages (from-to)749-758
Number of pages11
JournalClinical Oncology
Issue number11
Publication statusPublished - 2019


Dive into the research topics of 'Current Role of Radiotherapy in Non-melanoma Skin Cancer'. Together they form a unique fingerprint.

Cite this